Germany In Vivo Cro Market Size & Outlook, 2024-2030
Germany in vivo cro market, 2018-2030 (US$M)
Related Markets
Germany in vivo cro market highlights
- The Germany in vivo cro market generated a revenue of USD 352.8 million in 2023 and is expected to reach USD 591.2 million by 2030.
- The Germany market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 352.8 million |
| Market revenue in 2030 | USD 591.2 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Germany accounted for 7.6% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 328.5 million by 2030.
Small molecule was the largest segment with a revenue share of 63.63% in 2024. Horizon Databook has segmented the Germany in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical & biotechnology industry in Germany is considered as one of the world’s largest industries across the globe. Moreover, numerous German companies specialize in providing contracts exclusively to pharmaceuticals and biotechnology companies worldwide.
A notable initiative called HEALTH MADE IN GERMANY, led by the German Federal Ministry for Economic Affairs and Energy (BMW), actively promotes the country’s contract research businesses. This initiative was aimed at supporting international organizations to establish contact with potential German suppliers and partners. This is anticipated to boost in vivo CRO market growth in Germany.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany in vivo cro market size, by modality type, 2018-2030 (US$M)
Germany In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
